Omega Diagnostics Group PLC
LSE:ODX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (0.5), the stock would be worth GBX2.2 (0% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.5 | GBX2.2 |
0%
|
| 3-Year Average | 0.5 | GBX2.2 |
0%
|
| 5-Year Average | 0.5 | GBX2.2 |
0%
|
| Industry Average | 0 | GBX0.11 |
-95%
|
| Country Average | 0 | GBX0.09 |
-96%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Omega Diagnostics Group PLC
LSE:ODX
|
5.2m GBP | 0.5 | -1.4 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.9T JPY | 9.6 | 39.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
59.4B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.2B CHF | 1.7 | 37.2 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
91B DKK | 6.7 | 23.2 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.2B USD | 3.3 | 32.1 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 3.7 | 32.5 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
905.8B JPY | 5.7 | 51.2 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 0.9 | -15.6 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.2T KRW | 19.6 | -37.2 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
37.7B CNY | 2.1 | 22.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0 |
| Max | 49 422.3 |
Other Multiples
Omega Diagnostics Group PLC
Glance View
Omega Diagnostics Group Plc is a holding company, which engages in the manufacture, development, and distribution of medical diagnostics products. The company is headquartered in Alva, Stirlingshire and currently employs 171 full-time employees. The company went IPO on 2004-03-18. The principal activities of the Company and its subsidiaries are the manufacture, development and distribution of medical diagnostics products. The firm operates through two segments: Health and Nutrition and Global Health. The Health and Nutrition segment specializes in the research, development and production of kits to aid the detection of immune reactions to food. The company also provides clinical analysis to the general public, clinics and health professionals as well as supplying the consumer Food Detective test. The Global Health segment specializes in the research, development, production and marketing of kits to aid the diagnosis of infectious diseases, including COVID-19. The firm's products include FoodPrint, Food Detective, CNS lab, VISITECT CD4 Advanced Disease, VISITECT COVID-19 IgM/IgA/IgG and VISITECT COVID-19 Antigen.
